Elicio Therapeutics Files Definitive Proxy Statement
Ticker: ELTX · Form: DEF 14A · Filed: Apr 9, 2025 · CIK: 1601485
| Field | Detail |
|---|---|
| Company | Elicio Therapeutics, Inc. (ELTX) |
| Form Type | DEF 14A |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, corporate-governance
TL;DR
Elicio Therapeutics (formerly Angion) filed its proxy statement. Shareholders vote soon.
AI Summary
Elicio Therapeutics, Inc. filed its definitive proxy statement on April 9, 2025, for the fiscal year ending December 31, 2024. The company, formerly known as Angion Biomedica Corp. until February 28, 2014, is headquartered in Boston, MA. This filing is a standard DEF 14A, indicating it concerns the solicitation of proxies from shareholders.
Why It Matters
This filing provides shareholders with essential information regarding company matters to be voted on, including director elections and executive compensation, allowing them to make informed decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial or operational information that would inherently increase risk.
Key Players & Entities
- Elicio Therapeutics, Inc. (company) — Registrant
- Angion Biomedica Corp. (company) — Former company name
- 0001601485-25-000062 (filing_id) — Accession Number
- 20250409 (date) — Filing Date
- 1231 (date) — Fiscal Year End
- 2834 (sic_code) — Standard Industrial Classification
- 451 D STREET, 5TH FLOOR, BOSTON, MA 02210 (address) — Business Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing details on matters to be voted upon.
When was Elicio Therapeutics, Inc. formerly known as?
Elicio Therapeutics, Inc. was formerly known as Angion Biomedica Corp. until February 28, 2014.
What is the fiscal year end for Elicio Therapeutics, Inc.?
The fiscal year end for Elicio Therapeutics, Inc. is December 31.
Where is Elicio Therapeutics, Inc. located?
Elicio Therapeutics, Inc. is located at 451 D Street, 5th Floor, Boston, MA 02210.
What is the SIC code for Elicio Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Elicio Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 9, 2025 regarding Elicio Therapeutics, Inc. (ELTX).